ArticleRMD open2017

Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients.

Sergio Prieto-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.